Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,211.8
19.6 (0.61%)

 

  • STI Straits Times Index
    3,211.8
    19.6 (0.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,591.5
    -0.6 (-0.04%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,510.3
    43.4 (0.16%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,893.0
    -10.6 (-0.37%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,180.2
    141.6 (0.61%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,102.3
    -15.1 (-0.25%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,100.3
    3.7 (0.18%)
    Index delayed 20 minutes
  • XAO XAO
    6,813.9
    36.2 (0.53%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 323.9M
  • Value: 319.5M
  • Rise: 149
  • Fall: 58
  • Unch: 622

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Tritech0.037-0.006
Rex Intl0.160+0.006
Golden Agri-Res0.235-
YZJ Shipbldg SGD1.010+0.015
Dyna-Mac0.124+0.006
Mapletree NAC Tr1.140-0.010
SingTel3.330+0.070
Mapletree Com Tr2.340+0.050
Spackman0.014-
SPHREIT1.080-0.030

World Indices

World Indices
Name Last Change
Nasdaq 8,506.2 -20.5
HSI 26,504.9 +38.0
HSCEI 10,468.9 +18.7
Jakarta 6,103.7 -13.7
Nikkei 225 23,180.2 +141.6
SSE Comp 2,887.2 -16.4
Shanghai A 3,024.9 -17.2
Shanghai B 254.4 -0.6
PSE Comp 0.0
KOSPI 2,099.8 +3.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CELLMID LIMITED CELLMID
Updated on 21 Nov 2019 (End of trading day)
Last (AUD): 0.240 Change: +0.010 High: 0.245 Remarks: -
Change (%): +4.35 Low: 0.230
Open 0.230 Yesterday's Close 0.22999999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 174,061 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.06118 Trailing EPS (AUD) e -0.06118 NAV (AUD) b 0.0606
PE a - Trailing PE f - Price / NAV b 3.9604
Dividend (AUD) d - Cash In Hand (AUD) g 0.0319 Issued & Paid-up Shares c 96,596,900
Dividend Yield (%) d - Price / Cash In Hand g 7.524 Treasury Shares h -
Beta - 75 Daysi -0.214 R-Squared - 75 Days(%)i 0.15 Market Cap (M) 23.183
Beta - 500 Daysi -3.511 R-Squared - 500 Days (%)i 0.09 Enterprise Value (M) 21.388
Piotroski F Score 4 Exchange Code CDY Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 68.32 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 21 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CELLMID LIMITED ASX 23.183 - - 3.9604 -
Industry Biotechnology ASX 2,586.758 56.754 56.532 14.9413 0.931
Local Peer CSL ASX 121,182.756 45.168 45.168 16.1941 0.994
Local Peer POLYNOVO LIMITED ASX 1,223.013 - - 46.8354 -
Local Peer AVITA MEDICAL LTD ASX 1,101.064 - - 36.8794 -
Local Peer MESOBLAST LTD ASX 949.059 - - 1.3845 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 491.024 - - 11.5789 -
Local Peer TELIX PHARMACEUTIC ASX 466.035 - - 10.7855 -
Local Peer NEXT SCIENCE LTD ASX 464.175 - - 13.3436 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 255.862 83.249 - 15.2522 -
Local Peer RESAPP HEALTH LIMITED ASX 201.914 - - 26.3636 -
Local Peer IMUGENE LIMITED ASX 216.891 - - 7.8947 -
Local Peer PHYLOGICA LIMITED ASX 154.059 - - 24.7826 -
Local Peer CYNATA THERAPEUTICS LTD ASX 126.197 - - 11.5023 -
Other Local Peers ONCOSIL MEDICAL LIMITED (ASX), IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), BIONOMICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), NOVITA HEALTHCARE LTD (ASX), RHINOMED LIMITED (ASX), BIOTRON (ASX), MEMPHASYS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), REGENEUS LTD (ASX), IMMURON LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CCP TECHNOLOGIES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 135,366.999 16.127 16.780 12.3883 2.456
Global Peer GILEAD SCIENCES INC NASDAQ 83,158.310 15.244 30.879 4.0360 3.515
Global Peer CELGENE CORP NASDAQ 77,035.923 19.040 13.101 6.3735 -
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,415.825 26.434 25.850 10.5486 -
Global Peer BIOGEN INC NASDAQ 52,050.299 11.748 9.647 3.7190 -
Global Peer ILLUMINA INC NASDAQ 45,988.950 55.677 47.265 10.3602 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 38,514.230 15.756 17.962 3.6665 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,231.344 76.681 22.604 5.1046 0.782
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,238.003 312.345 16.485 2.3380 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), ALNYLAM PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), GENSCRIPT BIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), Lonza (SGX), SPARK THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), 3SBIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), ALKERMES PLC (NASDAQ), NATERA INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), HALOZYME THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), UNIQURE N.V. (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), INSMED INC (NASDAQ), HAOHAI BIOTEC (HKEx), AIMMUNE THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), KODIAK SCIENCES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), RADIUS HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), INTREXON CORP (NASDAQ), VIVA BIOTECH (HKEx), LUMINEX CORP(DEL) (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ASCENTAGE-B (HKEx), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CORTEXYME INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ASCLETIS-B (HKEx), TRANSLATE BIO INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), KADMON HLDGS INC (NYSE), HOMOLOGY MEDICINES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOMAB BIO-B (HKEx), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), AGENUS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), XBIOTECH INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), RETROPHIN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ESSEX BIO-TECH (HKEx), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ARDELYX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERUS B V (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MACROGENICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BELLUS HEALTH INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), HARPOON THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), MEDICINOVA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), LEE'S PHARM (HKEx), MOLECULAR TEMPLATES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PERSONALIS INC (NASDAQ), GERON CORP (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), KAMADA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CHIASMA INC (NASDAQ), DPHARMA (Bursa), ATHERSYS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PFENEX INC (NYSE American), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), AFFIMED N V (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NANOVIRICIDES INC (NYSE American), JOUNCE THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), BBI LIFE SCI (HKEx), LIMINAL BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), FORTRESS BIOTECH INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), IMV INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), SESEN BIO INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NANTKWEST INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), BIOXCEL THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ARAVIVE INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ADURO BIOTECH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), COHBAR INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CEL-SCI CORP (NYSE American), OTONOMY INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), INFLARX N V (NASDAQ), VERMILLION INC (NASDAQ), VERASTEM INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), TREVENA INC (NASDAQ), EQUILLIUM INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ORGENESIS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CT ENTERPRISE (HKEx), DIAMEDICA THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), PORT (SET), BELLICUM PHARMACEUTICALS (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), NEON THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), EVOGENE LTD (NASDAQ), SAVARA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), REGENT PACIFIC (HKEx), APTEVO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), BIOSINO BIO-TEC (HKEx), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ORAGENICS INC (NYSE American), SEELOS THERAPEUTICS INC (NASDAQ), ISORAY INC (NYSE American), EXTRAWELL PHAR (HKEx), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), CO DIAGNOSTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), TOCAGEN INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), VAXART INC (NASDAQ), Suntar Eco-City^ (SGX), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), BIOCEPT INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), TROVAGENE INC (NASDAQ), IBIO INC (NYSE American), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), HAO WEN HLDGS (HKEx), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ADVAXIS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MEGASUN (Bursa), NOVABAY PHARMACEUTICALS INC (NYSE American), ARCA BIOPHARMA INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ACHIEVE LIFE SCIENCE INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MGRC (Bursa), CYCLACEL PHARMA IN (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), QT Vascular (SGX), ENDRA LIFE SCIENCES INC (NASDAQ), OCUGEN INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.025
+11.63 %
10 Days -+0.030
+14.29 %
20 Days -+0.010
+4.35 %
Medium Term Return 3 Months -+0.025
+11.63 %
6 Months -+0.045
+23.08 %
1 Year --0.065
-21.31 %
Long Term Return 2 Years --0.160
-40.00 %
3 Years --0.340
-58.62 %
5 Years --0.320
-57.14 %
Annualised Return Annualised --
-15.59 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.165 - 0.325 Change From 1 Year Low +0.075 % Change From 1 Year Low (%) +45.45
Change From 1 Year High -0.085 % Change From 1 Year High (%) -26.15
2 Years Range 0.019 - 0.570 Change From 2 Years Low +0.221 % Change From 2 Years Low (%) +1163.16
Change From 2 Years High -0.330 % Change From 2 Years High (%) -57.89
5 Years Range 0.019 - 0.880 Change From 5 Years Low +0.221 % Change From 5 Years Low (%) +1163.16
Change From 5 Years High -0.640 % Change From 5 Years High (%) -72.73
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Cellmid Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. It operates through the following segments: research and development of diagnostics and therapeutics; and research, development and marketing of hair care products. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Nov 2019 0.230 0.245 0.230 0.240 174,061 -
20 Nov 2019 0.235 0.235 0.230 0.230 68,565 -
19 Nov 2019 0.230 0.235 0.230 0.230 38,500 -
18 Nov 2019 0.230 0.235 0.225 0.230 99,293 -
15 Nov 2019 0.225 0.230 0.225 0.230 16,292 -
14 Nov 2019 0.220 0.230 0.215 0.215 91,419 -
13 Nov 2019 0.210 0.210 0.210 0.210 62,807 -
12 Nov 2019 0.210 0.210 0.210 0.210 108,345 -
11 Nov 2019 0.210 0.210 0.210 0.210 18,475 -
08 Nov 2019 0.220 0.220 0.210 0.220 188,248 -
07 Nov 2019 0.230 0.230 0.210 0.210 28,581 -
06 Nov 2019 0.240 0.240 0.230 0.230 239,754 -
05 Nov 2019 0.215 0.225 0.215 0.225 92,983 -
04 Nov 2019 0.210 0.210 0.210 0.210 51,535 -
01 Nov 2019 0.210 0.210 0.210 0.210 30,635 -
31 Oct 2019 0.205 0.205 0.205 0.205 8,843 -
30 Oct 2019 0.210 0.210 0.210 0.210 51,766 -
29 Oct 2019 0.220 0.225 0.210 0.210 105,000 -
28 Oct 2019 0.225 0.225 0.225 0.225 2,380 -
25 Oct 2019 0.220 0.220 0.210 0.210 66,130 -
24 Oct 2019 0.230 0.230 0.220 0.230 114,603 -
23 Oct 2019 0.205 0.230 0.205 0.230 310,385 -
Summary
Current 2 Weeks
(08 Nov 2019 to 21 Nov 2019)
0.220 0.245 0.210 0.240 866,005 -
Previous 2 Weeks
(25 Oct 2019 to 07 Nov 2019)
0.220 0.245 0.210 0.210 677,607 -
4 Weeks from
(27 Sep 2019 to 24 Oct 2019)
0.240 0.245 0.210 0.230 1,551,623 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.